Lets (2.5mg) 10 Tablets
Letrozole 2.5mg tablets for hormone-positive breast cancer (postmenopausal).
Lets (2.5mg) contains letrozole, an aromatase inhibitor used for hormone receptor-positive breast cancer in postmenopausal women. Reduces oestrogen production. Take as directed; do not stop without medical advice.
Purpose
Treatment of hormone receptor-positive early or advanced breast cancer in postmenopausal women; adjuvant or metastatic as per indication.
Ingredients
Letrozole 2.5mg per tablet.
Warnings
Prescription only. Not for use in premenopausal women or during pregnancy. May reduce bone density; monitor as advised. Report chest pain or leg swelling.
Side Effects
Hot flushes, fatigue, arthralgia, osteoporosis, hypercholesterolaemia. Report bone pain, fractures, or signs of blood clots.
Storage Instructions
Store below 25°C in a dry place. Keep in original pack; protect from moisture.
| Brand | Genix |
| Status | Active |